Cosmetic cross-reference

Fructose

CAS 57-48-7

Fructose (CAS 57-48-7) is a Phase 2 pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Fructose

CAS Number

57-48-7

UNII

6YSS42VSEV

InChIKey

BJHIKXHVCXFQLS-UYFOZJQFSA-N

ChEMBL ID

CHEMBL1232863

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL1232863 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 4 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	AC50	30000 nM	31	-
-	IC50	19976.309999999998 nM	1	-
-	EC50	12589.25 nM	1	-
Glycine receptor subunit alpha-1 Ion channel	EC50	4.9	-	Homo sapiens

SOURCE DrugCentral 1 association

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Vaginal flatulence	21	117.727	10064227

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
Fructose	4570	SU	MTHSPL
FRUCTOSE	4570	SU	MTHSPL
fructose	4570	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Fructose used for in pharmaceutical contexts?

Fructose (CAS 57-48-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Fructose?

Fructose has 0 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Vaginal flatulence. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Fructose also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Fructose with EU status "permitted".

What clinical phase is Fructose in?

Fructose is rendered with ChEMBL max phase 2.

What bioactivity targets are documented for Fructose?

Fructose has 3 bioactivity rows in this page query. Rendered target entries include Glycine receptor subunit alpha-1.